Clinical Trial Update: A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI [NA]

View source ↗

Summary

The study evaluating 11-month ticagrelor monotherapy after one month of dual antiplatelet therapy following PCI has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Sino Medical Sciences Technology Inc. | Conditions: Coronary Artery Disease | NA | Status: WITHDRAWN